🇺🇸 FDA
Patent

US 6630144

Monoclonal antibodies to Ebola glycoprotein

expired A61KA61K2039/505A61K39/00

Quick answer

US patent 6630144 (Monoclonal antibodies to Ebola glycoprotein) held by The United States of America as represented by the Secretary of the Army expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61K39/00, A61P, A61P31/14